Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Journal of Cellular Biochemistry|March 21, 2007
Androgen receptor stimulates bone sialoprotein (BSP) gene transcription via cAMP response element and activator protein 1/glucocorticoid response elementsHideki Takai, Youhei Nakayama, Dong-Soon Kim, et al.
Journal of Cellular Physiology|April 28, 2006
Insulin-like growth factor-I increases bone sialoprotein (BSP) expression through fibroblast growth factor-2 response element and homeodomain protein-binding site in the proximal promoter of the BSP geneYouhei Nakayama, Yu Nakajima, Naoko Kato, et al.
Journal of Movement Disorders|April 25, 2025
Safety and efficacy of istradefylline in Parkinson's disease patients with and without pre-existing dyskinesia: Pooled analysis of 8 randomized controlled trialsNobutaka Hattori, Lawrence Elmer, Stuart H Isaacson, et al.
Journal of Periodontology|September 21, 2005
Amelogenin stimulates bone sialoprotein (BSP) expression through fibroblast growth factor 2 response element and transforming growth factor-beta1 activation element in the promoter of the BSP geneEmi Shimizu, Ryoichiro Saito, Youhei Nakayama, et al.
Journal of the American Chemical Society|March 5, 2017
Demonstration of a Light-Driven SO42- Transporter and Its Spectroscopic CharacteristicsAkiko Niho, Susumu Yoshizawa, Takashi Tsukamoto, et al.
Microbes and Environments|March 20, 2018
Presence of a Haloarchaeal Halorhodopsin-Like Cl- Pump in Marine BacteriaYu Nakajima, Takashi Tsukamoto, Yohei Kumagai, et al.
The Journal of Biological Chemistry|July 2, 2016
Structural Mechanism for Light-driven Transport by a New Type of Chloride Ion Pump, Nonlabens marinus Rhodopsin-3Toshiaki Hosaka, Susumu Yoshizawa, Yu Nakajima, et al.
International Journal of Systematic and Evolutionary Microbiology|July 18, 2018
Amylibacter kogurei sp. nov., a novel marine alphaproteobacterium isolated from the coastal sea surface microlayer of a marine inletShu-Kuan Wong, Susumu Yoshizawa, Yu Nakajima, et al.
Crohn'S & Colitis 360|February 13, 2023
Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative ColitisJaroslaw Kierkus, Marina Pesegova, Maria Klopocka, et al.
Crohn'S & Colitis 360|February 13, 2023
Corrigendum to: Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative ColitisJaroslaw Kierkus, Marina Pesegova, Maria Klopocka, et al.
Pageof 5